Aytu Biopharma, Inc

Ownership Transactions Reported by 13 Insiders

Symbol
AYTU on Nasdaq
Location
7900 E. Union Avenue, Suite 920, Denver, CO

There are no Buy or Sell transactions made by insiders since 2/3/2024

Aytu Biopharma, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Armistice Capital, Llc Director $5.02M Mar 20, 2021
Nantahala Capital Management, LLC 10%+ Owner $2.03M Jun 14, 2024
Gary Cantrell Director $307K Dec 21, 2022
Greg Pyszczymuka Chief Commercial Officer $44.1K Dec 31, 2024
Ryan J. Selhorn Chief Financial Officer $29.7K Nov 11, 2024
Carl Dockery Director $19.5K Nov 6, 2024
Vivian H. Liu Director $18.4K Nov 6, 2024
Abhinav Jain Director $17.8K Nov 6, 2024
John Donofrio Jr. Director $7.03K Nov 6, 2024
Christopher Brooke Chief Operating Officer Aug 11, 2023
K. Oki Chief Financial Officer Aug 11, 2023
Joshua R. Disbrow Chief Executive Officer, Director Nov 6, 2024
Jarrett Disbrow Chief Business Officer Nov 6, 2024

Recent Insider Transactions by Companies or Individuals for Aytu Biopharma, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.